These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23165314)

  • 1. The Peru cervical cancer prevention study (PERCAPS): community-based participatory research in Manchay, Peru.
    Levinson KL; Abuelo C; Chyung E; Salmeron J; Belinson SE; Sologuren CV; Ortiz CS; Vallejos MJ; Belinson JL
    Int J Gynecol Cancer; 2013 Jan; 23(1):141-7. PubMed ID: 23165314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Peru Cervical Cancer Screening Study (PERCAPS): the design and implementation of a mother/daughter screen, treat, and vaccinate program in the Peruvian jungle.
    Abuelo CE; Levinson KL; Salmeron J; Sologuren CV; Fernandez MJ; Belinson JL
    J Community Health; 2014 Jun; 39(3):409-15. PubMed ID: 24276617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Peru Cervical Cancer Prevention Study (PERCAPS): the technology to make screening accessible.
    Levinson KL; Abuelo C; Salmeron J; Chyung E; Zou J; Belinson SE; Wang G; Ortiz CS; Vallejos CS; Belinson JL
    Gynecol Oncol; 2013 May; 129(2):318-23. PubMed ID: 23385153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer: problem solved? Vaccinating girls against human papillomavirus.
    Crosbie EJ; Brabin L
    BJOG; 2010 Jan; 117(2):137-42. PubMed ID: 20050177
    [No Abstract]   [Full Text] [Related]  

  • 5. Perceptions of HPV and cervical cancer among Haitian immigrant women: implications for vaccine acceptability.
    Kobetz E; Menard J; Hazan G; Koru-Sengul T; Joseph T; Nissan J; Barton B; Blanco J; Kornfeld J
    Educ Health (Abingdon); 2011 Dec; 24(3):479. PubMed ID: 22267344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial.
    Denny L; Kuhn L; De Souza M; Pollack AE; Dupree W; Wright TC
    JAMA; 2005 Nov; 294(17):2173-81. PubMed ID: 16264158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fewer shots proposed to increase uptake of HPV vaccine.
    Dorans K
    Nat Med; 2010 Aug; 16(8):832-3. PubMed ID: 20689528
    [No Abstract]   [Full Text] [Related]  

  • 8. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.
    FUTURE II Study Group
    N Engl J Med; 2007 May; 356(19):1915-27. PubMed ID: 17494925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,
    Bratti MC; Rodríguez AC; Schiffman M; Hildesheim A; Morales J; Alfaro M; Guillén D; Hutchinson M; Sherman ME; Eklund C; Schussler J; Buckland J; Morera LA; Cárdenas F; Barrantes M; Pérez E; Cox TJ; Burk RD; Herrero R
    Rev Panam Salud Publica; 2004 Feb; 15(2):75-89. PubMed ID: 15030652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL) in Japanese women aged 18-26 years.
    Yoshikawa H; Ebihara K; Tanaka Y; Noda K
    Cancer Sci; 2013 Apr; 104(4):465-72. PubMed ID: 23331518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scaling up cervical cancer prevention in Western Kenya: Treatment access following a community-based HPV testing approach.
    Mungo C; Ibrahim S; Bukusi EA; Truong HM; Cohen CR; Huchko M
    Int J Gynaecol Obstet; 2021 Jan; 152(1):60-67. PubMed ID: 32347550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial.
    Shing JZ; Hu S; Herrero R; Hildesheim A; Porras C; Sampson JN; Schussler J; Schiller JT; Lowy DR; Sierra MS; Carvajal L; Kreimer AR;
    Lancet Oncol; 2022 Jul; 23(7):940-949. PubMed ID: 35709811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of the quadrivalent human papillomavirus vaccine against cervical dysplasia in Manitoba, Canada.
    Mahmud SM; Kliewer EV; Lambert P; Bozat-Emre S; Demers AA
    J Clin Oncol; 2014 Feb; 32(5):438-43. PubMed ID: 24395857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Qualitative Study of Parental Knowledge and Perceptions of Human Papillomavirus and Cervical Cancer Prevention in Rural Central Java, Indonesia: Understanding Community Readiness for Prevention Interventions.
    Spagnoletti BRM; Bennett LR; Wahdi AE; Wilopo SA; Keenan CA
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2429-2434. PubMed ID: 31450917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Human papillomavirus (HPV) vaccines--a new method for the prevention of cervical cancer].
    Friedek DA; Ekiel AM; Martirosian G
    Wiad Lek; 2007; 60(1-2):34-8. PubMed ID: 17607966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
    ; Dillner J; Kjaer SK; Wheeler CM; Sigurdsson K; Iversen OE; Hernandez-Avila M; Perez G; Brown DR; Koutsky LA; Tay EH; García P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch FX; Joura EA; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Maansson R; Lu S; Vuocolo S; Hesley TM; Barr E; Haupt R
    BMJ; 2010 Jul; 341():c3493. PubMed ID: 20647284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papilloma virus vaccination in Nepal: an initial experience in Nepal.
    Singh Y; Shah A; Singh M; Verma S; Shrestha BM; Vaidya P; Nakarmi RP; Shrestha SB
    Asian Pac J Cancer Prev; 2010; 11(3):615-7. PubMed ID: 21039025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
    Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
    J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
    Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
    BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.